3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
87
Breast Neoplasms
49
Prostatic Neoplasms
42
Squamous Cell Carcinoma of Head and Neck
34
Lung Neoplasms
24
Neoplasms
19
Stomach Neoplasms
18
Head and Neck Neoplasms
17
Neoplasm Metastasis
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Urinary Bladder Neoplasms
13
Carcinoma, Transitional Cell
11
Triple Negative Breast Neoplasms
10
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Carcinoma, Squamous Cell
8
Adenocarcinoma
8
Non-Muscle Invasive Bladder Neoplasms
7
HER2-positive Breast Cancer
7
Melanoma
6
Carcinoma
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms, Castration-Resistant
5
Nasopharyngeal Carcinoma
5
Esophageal Squamous Cell Carcinoma
5
Esophageal Neoplasms
5
Advanced Solid Tumors
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
LY3023414
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
amino-acid, glucose, and electrolyte solution
1
Vincristine
1
Vemurafenib
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Docetaxel
×
1 year
×
Clear all
No trials found.